On September 17, 2024, BioCardia received notice from Nasdaq confirming that the Company has demonstrated compliance with Listing Rule 5550 (b) (1) (the “Equity Rule”) of The Nasdaq Stock Market.
Q4 2024 Earnings Call Transcript September 12, 2024 Farmer Bros. Co. misses on earnings expectations. Reported EPS is ...
New Nano-Grid System ‘SOLIS’ and ‘COR‘ Stores 4,000Wh or more of Clean Energy Daily, Offering Modular, Portable Power ...
Strengthens Rare Disease segment as largest driver of future growth, adding approximately $105 million in 2024 revenue on a pro forma basisAdds two durable commercial assets ILUVIEN® and YUTIQ® with ...
The firm was notified by Nasdaq on 5 July that it was not in compliance with the minimum bid price requirement as its ADSs had closed below $1 for 30 consecutive trading days. “Following the ...
The Nasdaq composite closed today at 18,013.98. Compared to yesterday’s close, the benchmark index rose by 440.68 points, or ...
The Nasdaq composite closed today at 17,628.06. Compared to yesterday’s close, the benchmark index rose by 35.93 points, or 0 ...
For nearly two decades, companies on the New York Stock Exchange (NYSE) have transferred their listings to Nasdaq. This year, Nasdaq is celebrating a major milestone, 500 listings have made the switch ...
The Nasdaq composite has historically had a high correlation with the S&P 500. The two indexes even share common components, ...